New Velocity Vials Technology Platform to Expand Industry Partnerships

Article

This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

Corning Pharmaceutical Technologies announced its Velocity Vials Technology Platform on June 8, 2023 to increase access to Corning’s Velocity Vial technology. This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

According to the company press release, Corning will expand its manufacturing footprint, localize its supply chains, and enable the purchase of Velocity Vials through a network of selling partners. The new partnership with Gerresheimer AG will combine Gerresheimer’s extensive glass converting expertise with Corning’s innovative external vial coating technology, which helps with co-manufacturing and selling Velocity Vials.

Shortly after, SGD Pharma joined and announced a joint venture with Corning that includes the opening of a new glass tubing facility and expanded access to Velocity Vial technology in India. Further, Velocity Vials are important to the global distribution of essential vaccines and medications during the COVID-19 pandemic, according to the company.

“We are starting to see a paradigm shift in the pharmaceutical primary-packing industry, where coated vials are becoming the new industry standard,” said Brendan Mosher, vice president and general manager, Corning Pharmaceutical Technologies, in a press release. “Velocity Vials have demonstrated immediate benefits for our customers. The adoption of the technology by leading pharmaceutical-packaging providers is yet another proof point of this evolution.”

Velocity Vials can improve filling-line efficiency by up to 50%, which lowers costs while also improving the quality. It can also reduce the likelihood of damage that leads to cracks, breaks, and cosmetic defects. The vials are made with Type 1 borosilicate glass and conform to ISO standard dimensions, and they can be dropped-in to existing operations with no significant changes or reporting to regulatory authorities, according to the company press release.

Source: Corning 

Recent Videos
Lee Cronin, founder and CEO of Chemify
Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, STERIS Life Sciences | Image Credit: Pharmaceutical Technology
Nicole Hunter, head of Global WMArchitect at Watson-Marlow Fluid Technology Solutions
Related Content
© 2024 MJH Life Sciences

All rights reserved.